Maimon Yossi

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$7,800.00
Insider Sells Quantity
13
Insider Sells Sum
$4.15M

Insider Activity of Maimon Yossi

The largest purchase of all time was on 2015-12-14 and amounted to 10000 shares of Protalix BioTherapeutics, Inc. for $7,800.

The largest sale of all time was on 2009-10-15 and amounted to 109700 shares of Protalix BioTherapeutics, Inc. for $1.04M.

Biography of Maimon Yossi

No biography is available at this moment.

2015-12-14PurchaseProtalix BioTherapeutics, Inc.
PLX
Vice President & CFO
10,000
0.01%
$0.78$7,800-2.56%
2012-05-02SaleProtalix BioTherapeutics, Inc.
PLX
VP, Chief Financial Officer
125,964
0.14%
$7.13$898,123-20.83%
2010-10-07SaleProtalix BioTherapeutics, Inc.
PLX
VP, Chief Financial Officer
70,000
0.0851%
$9.67$676,900-31.35%
2010-09-07SaleProtalix BioTherapeutics, Inc.
PLX
VP, Chief Financial Officer
31,500
0.0388%
$8.16$257,040-14.43%
2010-09-03SaleProtalix BioTherapeutics, Inc.
PLX
VP, Chief Financial Officer
38,500
0.0469%
$8.00$308,000-13.13%
2009-10-16SaleProtalix BioTherapeutics, Inc.
PLX
VP, Chief Financial Officer
40,300
0.0532%
$9.35$376,805-24.1%
2009-10-15SaleProtalix BioTherapeutics, Inc.
PLX
VP, Chief Financial Officer
109,700
0.1446%
$9.50$1.04M-25.35%
2009-07-07SaleProtalix BioTherapeutics, Inc.
PLX
VP, Chief Financial Officer
10,000
0.0132%
$5.01$50,100+40.4%
2009-07-06SaleProtalix BioTherapeutics, Inc.
PLX
VP, Chief Financial Officer
40,000
0.0549%
$5.13$205,200+42.42%
2009-05-18SaleProtalix BioTherapeutics, Inc.
PLX
VP, Chief Financial Officer
30,000
0.0416%
$4.00$120,000+83.38%
2009-03-13SaleProtalix BioTherapeutics, Inc.
PLX
VP, Chief Financial Officer
7,500
0.0102%
$2.23$16,725+218.06%
2009-03-12SaleProtalix BioTherapeutics, Inc.
PLX
VP, Chief Financial Officer
32,241
0.0425%
$2.22$71,575+209.01%
2009-03-11SaleProtalix BioTherapeutics, Inc.
PLX
VP, Chief Financial Officer
8,849
0.0121%
$2.30$20,353+209.5%
2008-02-25SaleProtalix BioTherapeutics, Inc.
PLX
VP, Chief Financial Officer
33,300
0.0443%
$3.18$105,761-17.78%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.